Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction

European Heart Journal

Volumn 17, Issue 3, 1996, Pages 382-387

  Zijlstra, F ^a   de Boer, R J ^a   Beukema, W P ^a   Liem, A L ^a   Reifferst, S ^a   Huysmans, D ^a   Hoorntje, J C A ^a   Suryapranata, H ^a   Simoons, M L ^a  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

Acute myocardial infarction; Coronary angioplasty; Streptokinase

Indexed keywords

FIBRINOLYTIC AGENT; RADIOISOTOPE; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; TREATMENT OUTCOME;

EID: 0029875360     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a014869     Document Type: Article

References (0)